Persistence and Effectiveness Across PsA Patient Subgroups with Guselkumab and IL-17 Inhibitors: 6-Month Results of the Psabiond Observational Study

Journal of Rheumatology · Published 2026-08-01 · DOI 10.3899/jrheum.2026-0447.143

Authors (13)

Proton Rahman, Laure Gossec, Mohamed Sharaf, Xenofon Baraliakos, Mitsumasa Kishimoto, Ruben Queiro Silva, Ennio Lubrano, Emmanouil Rampakakis, László Köleséri, Karissa Lozenski, Enrique Soriano, Frank Behrens, Stefan Siebert

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Rahman, P., Gossec, L., Sharaf, M., et al. (2026). Persistence and Effectiveness Across PsA Patient Subgroups with Guselkumab and IL-17 Inhibitors: 6-Month Results of the Psabiond Observational Study. Journal of Rheumatology. https://doi.org/10.3899/jrheum.2026-0447.143

Related articles